Author details

Full Name

Barbara L Weber

Affiliation

Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania

ORCID

Career Start Year

1988

Papers

263

H Index

100

Expertise

CM4AI Collaborator

Andrej Sali (CM4AI)

PMID	Paper Title	Journal Title	Published Year
34320204	Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores.	J Natl Cancer Inst	2022
34320204	Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores.	J Natl Cancer Inst	2022
33990587	Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.	Nat Commun	2021
33990587	Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.	Nat Commun	2021
31712683	Synthetic lethality as an engine for cancer drug target discovery.	Nat Rev Drug Discov	2020
31712683	Synthetic lethality as an engine for cancer drug target discovery.	Nat Rev Drug Discov	2020
30559381	Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.	Nature	2019
30559381	Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.	Nature	2019
30643118	Author Correction: Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features.	Nat Commun	2019
30643118	Author Correction: Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features.	Nat Commun	2019
30327465	Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features.	Nat Commun	2018
30327465	Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features.	Nat Commun	2018
28183333	Erratum to: Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer.	Breast Cancer Res	2017
28183333	Erratum to: Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer.	Breast Cancer Res	2017
27368372	Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer.	Breast Cancer Res	2016
27368372	Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer.	Breast Cancer Res	2016
22058146	A combined array-based comparative genomic hybridization and functional library screening approach identifies mir-30d as an oncomir in cancer.	Cancer Res	2012
22460905	The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.	Nature	2012
22058146	A combined array-based comparative genomic hybridization and functional library screening approach identifies mir-30d as an oncomir in cancer.	Cancer Res	2012
22460905	The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.	Nature	2012
21563232	Frequent genetic abnormalities of the PI3K/AKT pathway in primary ovarian cancer predict patient outcome.	Genes Chromosomes Cancer	2011
21563232	Frequent genetic abnormalities of the PI3K/AKT pathway in primary ovarian cancer predict patient outcome.	Genes Chromosomes Cancer	2011
22110403	Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.	PLoS Biol	2011
22110403	Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.	PLoS Biol	2011
19862823	Distinct MHC gene expression patterns during progression of melanoma.	Genes Chromosomes Cancer	2010
21107320	COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.	Nature	2010
21060860	Common genetic variants and modification of penetrance of BRCA2-associated breast cancer.	PLoS Genet	2010
20571075	Sensitivity of cancer cells to Plk1 inhibitor GSK461364A is associated with loss of p53 function and chromosome instability.	Mol Cancer Ther	2010
20389018	HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype.	J Clin Invest	2010
19862823	Distinct MHC gene expression patterns during progression of melanoma.	Genes Chromosomes Cancer	2010
20233875	Serial transcriptome analysis and cross-species integration identifies centromere-associated protein E as a novel neuroblastoma target.	Cancer Res	2010
21107320	COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.	Nature	2010
21060860	Common genetic variants and modification of penetrance of BRCA2-associated breast cancer.	PLoS Genet	2010
20571075	Sensitivity of cancer cells to Plk1 inhibitor GSK461364A is associated with loss of p53 function and chromosome instability.	Mol Cancer Ther	2010
20233875	Serial transcriptome analysis and cross-species integration identifies centromere-associated protein E as a novel neuroblastoma target.	Cancer Res	2010
20389018	HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype.	J Clin Invest	2010
19276661	Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues.	Cancer Biol Ther	2009
19317917	Integrated analysis of breast cancer cell lines reveals unique signaling pathways.	Genome Biol	2009
19276661	Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues.	Cancer Biol Ther	2009
19226609	Distinct patterns of DNA copy number alterations associate with BRAF mutations in melanomas and melanoma-derived cell lines.	Genes Chromosomes Cancer	2009
19226609	Distinct patterns of DNA copy number alterations associate with BRAF mutations in melanomas and melanoma-derived cell lines.	Genes Chromosomes Cancer	2009
19317917	Integrated analysis of breast cancer cell lines reveals unique signaling pathways.	Genome Biol	2009
18165634	Genetic variants of uncertain significance: flies in the ointment.	J Clin Oncol	2008
19074899	MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer.	Cancer Res	2008
18059191	miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer.	Cancer Biol Ther	2008
18676756	A phase I trial of the oral, multikinase inhibitor sorafenib in combination with carboplatin and paclitaxel.	Clin Cancer Res	2008
18621610	Method of primary tumor detection as a risk factor for local and distant recurrence after breast-conservation treatment for early-stage breast cancer.	Clin Breast Cancer	2008
18565892	Phase I and pharmacokinetic study of lapatinib and docetaxel in patients with advanced cancer.	J Clin Oncol	2008
18458333	Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer.	Proc Natl Acad Sci U S A	2008
18373407	Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations.	Genet Test	2008

1 - 50 of 526

Florentine S Hilbers

Netherlands Cancer Institute

Career Start Year 2012

Number of shared co-authors 21

Leonard Da Silva

Pathology Queensland The Royal Brisbane and Women's Hospital Brisbane Qld Australia.

Career Start Year 2007

Number of shared co-authors 21

Larissa A Korde

Clinical Investigations Branch, National Cancer Institute

Career Start Year 2004

Number of shared co-authors 17

Siddhartha Deb

Olivia Newton-John Cancer Research Institute

Career Start Year 2002

Number of shared co-authors 1

Juliet D French

QIMR Berghofer Medical Research Institute

Career Start Year 2001

Number of shared co-authors 58

Jonine D Figueroa

The Usher Institute, The University of Edinburgh

Career Start Year 2001

Number of shared co-authors 67

Teresa Ram??n y Cajal

Familial Cancer Clinic, Hospital Sant Pau

Career Start Year 2000

Number of shared co-authors 48

Gillian Mitchell

Familial Cancer Centre Peter MacCallum Cancer Centre Parkville Victoria 0 Australia.

Career Start Year 1998

Number of shared co-authors 59

Dirce Maria Carraro

AC Camargo Cancer Center

Career Start Year 1998

Number of shared co-authors 9

Ingrid Hedenfalk

Lund University and Skane University Hospital

Career Start Year 1997

Number of shared co-authors 12

Marbin Pineda

Center for Cancer Research, National Cancer Institute

Career Start Year 1995

Number of shared co-authors 18

Rebecca Sutphen

College of Medicine, University of South Florida

Career Start Year 1995

Number of shared co-authors 56

Susan J Done

University Health Network

Career Start Year 1994

Number of shared co-authors 3

Aleksandra To??oczko-Grabarek

Pomeranian Medical University in Szczecin

Career Start Year 1994

Number of shared co-authors 53

David G Huntsman

University of British Columbia

Career Start Year 1994

Number of shared co-authors 81

Jacek Gronwald

International Hereditary Cancer Center, Pomeranian Medical University

Career Start Year 1993

Number of shared co-authors 72

Rosemary L Balleine

Westmead Institute for Medical Research, The University of Sydney

Career Start Year 1993

Number of shared co-authors 54

Christine B Ambrosone

Roswell Park Comprehensive Cancer Center

Career Start Year 1993

Number of shared co-authors 66

Peggy L Porter

Fred Hutchinson Cancer Research Center

Career Start Year 1991

Number of shared co-authors 9

Caroline Seynaeve

Erasmus Medical Center

Career Start Year 1990

Number of shared co-authors 65

Ben Ho Park

Vanderbilt University Medical Center

Career Start Year 1990

Number of shared co-authors 14

James M Ford

Stanford University

Career Start Year 1989

Number of shared co-authors 16

Ming K Lee

University of Washington

Career Start Year 1988

Number of shared co-authors 6

Lynn G Dressler

Duke University Research Institute

Career Start Year 1985

Number of shared co-authors 12

Craig D Shriver

Walter Reed National Military Medical Center

Career Start Year 1985

Number of shared co-authors 4

Olli Kallioniemi

Karolinska Institute

Career Start Year 1984

Number of shared co-authors 19

Vessela N Kristensen

Faculty of Clinical Medicine, University of Oslo

Career Start Year 1983

Number of shared co-authors 72

Edison T Liu

USA The Jackson Laboratory Cancer Center

Career Start Year 1982

Number of shared co-authors 10

Heather Thorne

Peter MacCallum Cancer Centre

Career Start Year 1982

Number of shared co-authors 49

Christopher C Benz

Buck Institute for Research on Aging

Career Start Year 1977

Number of shared co-authors 15

row(s) 1 - 30 of 30

Judy E Garber

Dana-Farber Cancer Institute

Co-authored papers 36

Katherine L Nathanson

Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center

Co-authored papers 34

Fergus J Couch

Mayo Clinic

Co-authored papers 34

Timothy R Rebbeck

Center for Cancer Equity and Engagement, Dana-Farber/Harvard Cancer Center

Co-authored papers 34

Michael R Stratton

Wellcome Sanger Institute

Co-authored papers 26

Kathleen A Calzone

National Institutes of Health, National Cancer Institute, Center for Cancer Research

Co-authored papers 24

Douglas F Easton

University of Cambridge

Co-authored papers 23

Claudine Isaacs

Co-authored papers 22

William D Foulkes

Segal Cancer Centre, Jewish General Hospital

Co-authored papers 18

David E Goldgar

University of Utah

Co-authored papers 16

Francis S Collins

University of Michigan ann arbor

Co-authored papers 13

Phillip A Futreal

The University of Texas MD Anderson Cancer Center

Co-authored papers 13

Susan M Domchek

Co-authored papers 12

Jan Lubinski

Pomeranian Medical University

Co-authored papers 10

Jenny Chang-Claude

German Cancer Research Center (DKFZ)

Co-authored papers 9

Anne-Marie Martin

Novartis Pharmaceuticals

Co-authored papers 9

Marcia S Brose

Co-authored papers 8

Settara C Chandrasekharappa

National Institutes of Health

Co-authored papers 8

Georgia Chenevix-Trench

QIMR Berghofer Medical Research Institute

Co-authored papers 8

Rosalind A Eeles

The Institute of Cancer Research

Co-authored papers 8

Javier Ben??tez

Instituto de Salud Carlos III

Co-authored papers 7

Lawrence C Brody

National Human Genome Research Institute, National Institutes of Health

Co-authored papers 7

Meenhard Herlyn

Ellen and Ronald Caplan Cancer Center, The Wistar Institute

Co-authored papers 7

Beth Y Karlan

David Geffen School of Medicine, University of California los angeles

Co-authored papers 7

John M Maris

Children's Hospital of Philadelphia

Co-authored papers 6

Andrew G Nicholson

Co-authored papers 6

Irene L Andrulis

University of Toronto

Co-authored papers 6

Mary-Claire King

University of Washington

Co-authored papers 6

Ana Osorio

Familial Cancer Clinical Unit, Spanish National Cancer Research Centre

Co-authored papers 6

Sarah Edkins

Co-authored papers 6

1 - 30

Author Details

Column Actions

Recommended Authors

Collaborators